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Summary: The present work investigated the effect of Morinda lucida (M. lucida) extract on isolated 
uterine smooth muscle of pregnant and non-pregnant mice. Pregnant and non-pregnant mice were 
pretreated with oral stilboesterol (0.1mg/kg body weight) and killed by cervical dislocation. Thin strips 
of the uterus were cut and mounted in a 20-ml organ bath containing De Jalon solution bubbled with 
95%O2-5% CO2 gas mixture. The strips were connected to a force transducer coupled to a Grass 7D 
Polygraph for the recording of isometric tension. Effects of graded concentrations of oxytocin (OXY; 
10-5–10-2 mol/L), acetylcholine (ACh; 10-9-10-5 mol/L) and M. lucida extract (0.015–1.5mg/ml) were 
recorded. Fresh uterine strips were then incubated with M. lucida extract for 5mins and cumulative 
response to OXY was repeated. Another set of fresh strips was incubated in L-NAME for 15mins and 
the cumulative responses to M.lucida extract were repeated. OXY resulted in increased contractile 
responses in both pregnant and non-pregnant uterine muscles. M. lucida resulted in relaxation of the 
uterine smooth muscle in both pregnant and non-pregnant mice at all doses. However, at 1.500mg/ml, 
M. lucida completely blocked spontaneous uterine contractions.  Following incubation with L-NAME, 
M. lucida extract led to a slightly greater relaxation of the uterine strips. In conclusion, M. lucida
reduced contractility of uterine smooth muscle in both pregnant and non-pregnant mice as well as 
blocking contractile responses to OXY and Ach in uterine smooth muscle of pregnant and non-
pregnant mice. There was no significant alteration of M. lucida activity by L-NAME suggesting that 
the action of the compound on uterine muscle is not associated with impaired nitric oxide synthase.
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Introduction
Morinda lucida (L.) Benth. (Rubiacae) is 
used in herbal decoctions in the treatment of 
“fevers” Sittie et al (1999), Lemmich et al 
(1999), malaria Watt (1962); Beyer-Bradwijk 
(1962) and diabetes Ettarh and Emeka (2004) in 
Africa. It has been reported that the main 
compounds that have useful antimalarial 
activities, which can be extracted from the stem 
bark and root of M lucida Benth are 
anthraquinones, digitolutein, rubiadin 1-methyl 
ether and damnacanthal  Sittie et al (1999); 
Lemmich et al (1999); Koumaglo et al (1992).  
It has been shown that anthraquinones also have 
antibacterial properties (Koumaglo et al, 1992). 
Studies have shown that administration of 
chloroquine to mice infected with Plasmodium 
yoeli nigeriensis parasites led to the survival of 
all the mice, while those treated with medicinal 
plants such as M. lucida exhibited various 
degrees of chemosuppression, which did not 
however lead to their survival (Agomo et al, 
1992). Also, M. lucida has been reported to 
induce relaxation of vascular smooth muscle via 
endothelium-dependent and –independent 
mechanisms, the former of which involves the 
nitric oxide-cGMP pathway (Ettarh and Emeka, 
2004).
Whereas these herbal preparations are 
widely used in pregnancy, not many reports 
have taken into consideration the effect of M. 
lucida on the uterus, pregnant or non-pregnant. 
We therefore investigated the effect of M. 
lucida on isolated uterine smooth muscle from 
non-pregnant and pregnant mice and the 
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M. lucida fresh leaves were collected in 
Lagos, Nigeria in March 2002 and authenticated 
by Prof. D. Olowokudejo of Department of 
Botany and Microbiology, University of Lagos, 
Akoka, Lagos, Nigeria.
Preparation of Extract
Leaves of ground M. lucida that have been 
previously dried, weighing 250g were Soxhlet-
extracted with water. The extract was 
concentrated under vacuum at 40oC, and 
appropriate stock solutions prepared on the day 
of the experiment.
Animal Preparation
The experiments were performed on 10 
pregnant and 10 non-pregnant mice, which were 
obtained from the Laboratory Animal House 
Department of the Lagos State University 
College of Medicine. They were provided with 
mice pellets and water ad libitum.  The mice 
were pretreated with 0.1 mg/kg-body weight of 
stilboesterol given orally 24 hours before the 
experiment. 
Preparation of Mice Uterine Strips
The mice were anaesthetized with 
urethane and sacrificed by cervical dislocation. 
The uterine horn was exposed by means of blunt 
dissection, freed of connective tissue and cut 
into strips of 2mm long. The strip was 
suspended on fine stainless steel stirrups in a 20 
ml organ bath and connected to a force 
transducer (Grass Model FT03), which was 
coupled to a 4-channel Grass Model 7D 
Polygraph for the recording of the isometric 
tension. The transducer was calibrated with 1g 
weight to give a 2cm paper deflection. The bath 
contained De Jalon solution Gamaniel et al 
(1995) of the following composition (1 L): 
NaCl-9g, NaHCO3-0.5g, Glucose-0.5g 10% 
KCl-4.2ml, 1M CaCl2-0.27ml). The solution 
was bubbled with a 95% O2-5% CO2 gas 
mixture. The temperature and pH were 
maintained at 37oC and 7.4 ± 0.2 respectively 
Experimental Protocols
Each tissue preparation was allowed to 
equilibrate for 60-90 min under a resting tension 
of 9.5mN. All investigations were carried out in 
spontaneously contracting uterine strips. Graded 
concentrations of oxytocin (OXY) 10-5-10-2 
mol/L were added into the organ bath and their 
effects noted. In addition, responses to graded 
concentrations of the following were 
investigated in fresh uterine strips from different 
mice after the equilibration period: 
acetylcholine (ACh; 10-9-10-5 mol/L) and M. 
lucida (0.015 – 1.500 mg/ml). The tissues were 
then incubated in 1.500 mg/ml of M. lucida for 
5 minutes after which the cumulative dose 
responses to OXY and ACh were repeated. 
Finally, graded dose response to M. lucida was 
investigated in different sets of tissues from 
different animals after incubation in 10-4M N-
nitro L-arginine methyl ester (L-NAME) for 15 
minutes. 
Statistics
For each cumulative dose response study, 
the EC50 values were calculated. The data are 
presented as means ± SEM and Student’s 
unpaired t-test was used to test for statistical 
differences among groups. P value less than 
0.05 was considered significant.
Figure 1: Typical tracing of the effect of administration of: (1)-M lucida alone, (2)-M lucida after 
incubation with L-NAME, (3)-Oxytocin after incubation with M lucida and (4)-Acetylcholine after 
incubation with M lucida, in uterine strips of (a)-non-pregnant and (b)-pregnant mice respectively.
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Table 1: EC50 and Maximum Tension Response (mN) due to administration of M lucida before and 
after incubating in L-NAME in non-pregnant and pregnant mice
















8.28±1.70 6.74±0.73 7.19±1.13 5.47±0.54
Results
Effect of M. lucida on Mice Uteri
All doses of M. lucida led to relaxation of 
spontaneous uterine contraction in non-pregnant 
and pregnant mice. However, there was no 
difference in the EC50 and maximum response 
of uterine smooth muscle of non-pregnant and 
pregnant mice to M. lucida (Table I).  Also, the 
frequency of contraction to M. lucida in the 
uterine strips of the experimental mice was 
similar (Figure 1).
Table 2: Effect of M lucida incubation on 
uterine spontaneous contractile response (%) to 
(a) oxytocin (OXY) and (b) acetylcholine (ACh)  
in non-pregnant and pregnant mice {frequency 
of spontaneous uterine contraction (contraction 
per min) in parenthesis}
(a)
Non-Pregnant  (n=5) Pregnant  (n=6)
Dose 
(IU/ml)
OXY alone OXY with 
M lucida


































*P<0.05 vs. non-pregnant uterine treated with M lucida
(b)
Non-Pregnant  (n=5) Pregnant  (n=6)
Dose 
(M)
ACh alone ACh with M 
lucida
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Figure 2: Line graph showing responses to M. lucida in uterine strips of (a) non-pregnant mice 
(Non-Preg, n=5), (b) pregnant mice (Preg, n=7), (c) non-pregnant mice (Non-P) after incubating in 
L-NAME; and (d) pregnant mice (Preg, n=7) after incubating in L-NAME. Each point represents a 
mean of the observation ± S.E.M
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Effect of M. lucida on Responses of Uterine 
Strips to OXY and ACh
Incubation in M. lucida (1.50 mg/ml) led 
to total blockade of contractile response to OXY 
in non-pregnant uterine strips of non-pregnant 
mice while uterine strips of pregnant mice 
produced slight contractile responses to 10-4 –
10-2 IU/ml of OXY (Table IIa). There was a 
significantly higher (P<0.03) degree and 
frequency of contractile response to 10-2 IU/ml 
of OXY in pregnant uterine strips of pregnant 
mice compared with uterine strips of non-
pregnant mice (Figure 1). However, incubation 
with M. lucida led to complete inhibition of 
contractile response to ACh in experimental 
mice (Figure 1).
Effect of L-NAME on Responses of Isolated 
Uterine Smooth Muscles to M. lucida in 
Experimental Mice
There was a shift to the right in the dose 
response curve to M. lucida in pregnant mice 
(Figure 1) after incubation of the uterine strips
in L-NAME (10-4 M) for 15 minutes. Also, 
relaxant effect of M. lucida on the strips at low 
dose (0.015 mg/ml) in the presence of L-NAME 
was significantly (P<0.05) attenuated. However, 
there was no significant difference in EC50 and 
maximum response to M. lucida alone or M. 
lucida with L-NAME in both groups (Table I). 
Discussion
The present experiments have shown that 
M. lucida has a relaxant effect on uterine 
smooth muscle of both non-pregnant and 
pregnant mice; inhibiting both the degree and 
frequency of contractile responses. There was 
no significant difference in the sensitivity of the 
uterine strips to M. lucida in non-pregnant or 
pregnant mice.
M. lucida at a concentration of 1.500 
mg/ml completely blocked the cumulative 
responses of the uterine strips to OXY (10-5-10-2 
IU/L) and ACh (10-9-10-5 mol/L) in both 
pregnant and non-pregnant mice. However, 
there was a slight contractile response in uterine 
smooth muscle of pregnant mice to high dose of 
OXY (10-2 IU/L) and ACh (10-5 M), which was 
significantly greater than those observed in 
uterine smooth muscles of non-pregnant mice. 
This might probably be due to increase in OXY 
receptors associated with pregnancy Silverthorn 
(2004), which may have been responsible for 
this observation in pregnant mice.
Anti-malarial drugs like chloroquine have 
been reported to possess inhibitory action on the 
uterus (Nwaigwe  et al, 1997). In many cases, 
chloroquine has been abused with its local use 
as an abortifacient effect without regards for its 
associated toxic effect (Raddy and Sinna, 2000).  
M. lucida is used for the treatment of malaria  
Sittie et al (1999), Lemmich et al (1999); Watt 
(1962), Beyer-Bradwijk (1962) and it is found 
to be cytotoxic, with LC50 values of 2.6 g/ml 
(Ajaiyeoba et al, 2006). Earlier works have 
reported that M. lucida has a vasorelaxant effect 
on vascular smooth muscle, which is due to 
endothelium-dependent and –independent 
mechanisms, the former of which involves the 
nitric oxide-cGMP pathway (Ettarh and Emeka, 
2004). Endothelial cells produce factors like 
nitric oxide (NO), prostacyclin and the 
endothelium-derived hyperpolarizing factor, 
which mediate the endothelium-dependent 
relaxation (Vapaatalo and Mervaala, 2001). The 
L-arginine-NO system has been demonstrated 
as possessing inhibitory effect on myometrial 
contractility (Kaya and Sarioglu, 1998). 
However, nitric oxide synthase inhibition 
appears to have no significant effect on M. 
lucida action on myometrial contractility in the 
present study.
In conclusion, this study demonstrates that 
M. lucida has a relaxant effect on isolated 
uterine smooth muscle of both non-pregnant and 
pregnant mice. This observation appears to be 
independent of bioavailability of nitric oxide in 
the uterus. However, further work investigating 
the effect of M. lucida on calcium mobilization 
from intracellular or extracellular stores will 
need to be explored. 
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